NCT00143338View on ClinicalTrials.gov

To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

December 31, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Inhaled insulin

Trial Locations (2)

Unknown

Pfizer Investigational Site, Fresno

Pfizer Investigational Site, San Antonio

Sponsors

Lead Sponsor

Pfizer

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Pfizer

INDUSTRY

NCT00143338 - To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. | Biotech Hunter | Biotech Hunter